Filing Details
- Accession Number:
- 0000950170-24-012838
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-08 16:37:35
- Reporting Period:
- 2024-02-06
- Accepted Time:
- 2024-02-08 16:37:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1572616 | Fractyl Health Inc. | GUTS | Surgical & Medical Instruments & Apparatus (3841) | 273553477 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1875614 | Ajay Royan | C/O Fractyl Health, Inc. 17 Hartwell Avenue Lexington MA 02421 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-02-06 | 5,160,301 | $0.00 | 5,160,301 | No | 4 | C | Indirect | See footnote |
Common Stock | Acquisiton | 2024-02-06 | 918,567 | $0.00 | 918,567 | No | 4 | C | Indirect | See footnote |
Common Stock | Acquisiton | 2024-02-06 | 333,333 | $15.00 | 1,251,900 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See footnote |
No | 4 | C | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series C-1 Preferred Stock | Disposition | 2024-02-06 | 4,025,764 | $0.00 | 1,875,938 | $0.00 |
Common Stock | Series C-2 Preferred Stock | Disposition | 2024-02-06 | 6,502,796 | $0.00 | 3,030,193 | $0.00 |
Common Stock | Series D Preferred Stock | Disposition | 2024-02-06 | 545,450 | $0.00 | 254,170 | $0.00 |
Common Stock | Series E Preferred Stock | Disposition | 2024-02-06 | 373,021 | $0.00 | 173,821 | $0.00 |
Common Stock | Series F Preferred Stock | Disposition | 2024-02-06 | 1,598,225 | $0.00 | 744,746 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock.
- Represents securities held by Mithril LP ("LP"). Mithril GP LP ("GP LP") is the general partner of LP and may be deemed to have shared voting and dispositive power with respect to the securities held by LP. The Reporting Person is the authorized person of GP LP and a member of the investment committee of GP LP, and in such capacity may be deemed to have beneficial ownership of the securities held by LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any.
- Represents securities held by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II"), which is the general partner of II LP, and each of UGP II and GP II may be deemed to have shared voting and dispositive power with respect to the securities held by II LP. The Reporting Person is the sole managing member of UGP II and a member of the investment committee of GP II, and in such capacity may be deemed to have beneficial ownership of the securities held by II LP. The Reporting Person disclaim such beneficial ownership except to the extent of his pecuniary interest therein, if any.